706 results about "Trimer" patented technology

The object of the present invention is to provide a carbon nanotube composition that does not impair the characteristics of the carbon nanotubes itself, allows the carbon nanotubes to be dispersed or solubilized in a solvent, does not cause separation or aggregation of the carbon nanotubes even during long-term storage, has superior electrical conductivity, film formability and moldability, can be easily coated or covered onto a base material, and the resulting coated film has superior moisture resistance, weather resistance and hardness; a composite having a coated film composed thereof; and, their production methods. In order to achieve this object, the present invention provides a carbon nanotube composition that contains a conducting polymer (a) or heterocyclic compound trimer (i), a solvent (b) and carbon nanotubes (c), and may additionally contain a high molecular weight compound (d), a basic compound (e), a surfactant (f), a silane coupling agent (g) and colloidal silica (h) as necessary; a composite having a coated film composed of the composition; and, their production methods.

The invention provides small molecule mimics of the Smac peptide that are dimer-like or trimer-like compounds having two or three amide-containing domains connected by a linker. These compounds are useful to promote apoptosis. The invention includes pharmaceutical compositions comprising such compounds and methods to use them to treat conditions including cancer and autoimmune disorders.

The present invention refers to fusion proteins comprising a TNF superfamily (TNFSF) cytokine or a receptor binding domain thereof fused to a trimerization domain and a nucleic acid molecule encoding the fusion protein. The fusion protein is present as a trimeric complex or as an oligomer thereof and is suitable for therapeutic, diagnostic and / or research applications.

A collagen scaffold domain, including a collagenous or collagen-like domain, which directs self-trimerization is provided. The collagen scaffold domain can be fused to one or more heterologous domains, such as an antibody domain. Methods for generating and using the scaffold domains and fusion proteins are also provided.

A process of manufacture of polytrimethylene ether glycol comprising:(a) polycondensing reactant comprising diol selected from the group consisting of 1,3-propanediol, 1,3-propanediol dimer and 1,3-propanediol trimer or mixtures thereof in the presence of acid polycondensation catalyst to form polytrimethylene ether glycol;(b) adding water to the polytrimethylene ether glycol and hydrolyzing the acid esters formed during the polycondensation to form a hydrolyzed mixture containing the polytrimethylene ether glycol and the hydrolyzed acid esters;(c) adding organic solvent that is miscible with water to the hydrolyzed mixture to form an aqueous-organic mixture comprising (i) organic phase containing polytrimethylene ether glycol and residual acid polycondensation catalyst from the polycondensing and (ii) water phase;(d) separating the water phase and the organic phase;(e) adding base to the separated organic phase to neutralize the residual acid polycondensation catalyst by forming salts of the residual acid polycondensation catalyst;(f) separating the organic phase into (i) liquid phase comprising the polytrimethylene ether glycol, the organic solvent and any residual water, and (ii) solid phase comprising the salts of the residual acid polycondensation catalyst and the base which is unreacted; and(g) removing the organic solvent and the residual water from the organic phase to obtain polytrimethylene ether glycol.

The invention discloses a 2-(2-(diphenyl phosphine) phenyl) oxazoline nickel halogenide series complex. Said invention provides the structure formula of said complex and its preparation method. Said invention also provides catalyst composition containing said complex and its application in ethylene oligopolymerization. Said catalyst composition has higher ethylene oligopolymerization activity, and the obtained oligomer takes ethylene dimmer and trimer as main components.

The invention relates to a preparation method of a photo-moisture dual cured hot melt polyurethane sealant. The preparation method comprises following steps: firstly, an HDI (hexamethylene diisocyanate) trimer reacts with a hydroxyl acrylate monomer, after the reaction, polyether polyol is added for continuous reaction, and a prepolymer A is obtained; bifunctional isocyanate reacts with crystalline polyester polyol and non-crystalline polyester polyol, and a prepolymer B is obtained; the prepolymer A and the prepolymer B are mixed in a certain ratio, then a photoinitiator, a catalyst, a coupling agent and the like are added, and the photo-moisture dual cured hot melt polyurethane sealant is obtained. The preparation method improves the defects of failure in rapid positioning of UV glue, low initial strength of the hot melt polyurethane sealant and the like, rapid positioning can be realized, the hot melt polyurethane sealant can achieve higher strength in a short time, and the hot melt polyurethane sealant can be used for bonding of appliances, furniture, electronic components and the like.

The present application is directed to stabilized envelope glycoprotein trimers. The trimers are stabilized by introducing disulfide bonds at certain sites in the gp41 ectodomain. DNA molecules encoding such trimers can be used to generate an immunogenic reaction.

Single chain trimer (SCT) molecules are disclosed, comprising an MHC antigen peptide sequence, a β2-microglobulin sequence and a full-length MHC class I heavy chain sequence, joined by linker sequences. Further described are nucleic acids encoding single chain trimers. Methods for expansion of antigen-specific T cell populations using single chain trimer molecules are also disclosed. In some configurations, these methods comprise co-culturing, in a first stage, CD8+ T cells from a donor with antigen presenting cells comprising an MHC antigen peptide, and co-culturing, in a second stage, the CD8+ T cells with cells comprising an SCT which has an MHC antigen peptide sequence identical to the sequence of the antigen peptide in the first stage. The methods can provide 10,000-100,000 fold expansion of antigen-specific CD8+ T cells within about 28 days after establishing culture, and can yield over 1 billion antigen-specific CD8+ T cells expanded from an individual donor.

The invention relates to highly cross-linked polyphosphazene hollow microspheres as well as a preparation method thereof, belonging to the technical field of organic micro-nanometer materials. The preparation method comprises the following steps: dissolving 4, 4-disulfydryl dithiophenol, phosphonitrilic chloride trimer and an acid-binding agent in an organic solvent for reaction; and after reaction, carrying out centrifugal separation on a solid product and washing and drying the solid product to obtain the polyphosphazene hollow microspheres. The highly cross-linked polyphosphazene hollow microspheres provided by the invention are prepared by a one-pot method by means of self-assembly of the reactant to a reactive template while a cross-linking agent is introduced, so that the whole preparation method is convenient and concise to implement.

The instant invention provides an isocyanate trimerisation catalyst system, a precursor formulation, a process for trimerising isocyanates, rigid foams made therefrom, and a process for making such foams. The trimerisation catalyst system comprises: (a) an imidazolium or imidazolinium cation; and (b) an isocyanate-trimer inducing anion; wherein said trimerisation catalyst system has a trimerisation activation temperature in the range of equal to or less than 73° C. The precursor formulation comprises: (1) at least 25 percent by weight of polyol, based on the weight of the precursor formulation; (2) less than 15 percent by weight of a trimerisation catalyst system, based on the weight of the precursor formulation, comprising; (a) an imidazolium or imidazolinium cation; and (c) an isocyanate-trimer inducing anion; wherein said trimerisation catalyst system has a trimerisation activation temperature in the range of equal to or less than 73° C.; and (3) optionally one or more surfactants, one or more flame retardants, water, one or more antioxidants, one or more auxiliary blowing agents, one or more urethane catalysts, one or more auxiliary trimerisation catalysts, or combinations thereof. The process for trimerisation of isocyanates comprises the steps of: (1) providing one or more monomers selected from the group consisting of an isocyanate, a diisocyanate, a triisocyanatetriisocyanate, oligomeric isocyanate, a salt of any thereof, and a mixture of any thereof; (2) providing a trimerisation catalyst system comprising; (a) an imidazolium or imidazolinium cation; and (b) an isocyanate-trimer inducing anion; (c) wherein said trimerisation catalyst system has a trimerisation activation temperature in the range of equal to or less than 73° C.; (3) trimerising said one or more monomers in the presence of said trimerisation catalyst; (4) thereby forming an isocyanurate trimer. The process for making the PIR foam comprises the steps of: (1) providing one or more monomers selected from the group consisting of an isocyanate, a diisocyanate, a triisocyanatetriisocyanate, oligomeric isocyanate, a salt of any thereof, and a mixture any thereof; (2) providing polyol; (3) providing a trimerisation catalyst system comprising; (a) an imidazolium or imidazolinium cation; and (b) an isocyanate-timer inducing anion; wherein said trimerisation catalyst system has a trimerisation activation temperature in the range of equal to or less than 73° C.; and (4) optionally providing one or more surfactants, one or more flame retardants, water, one or more antioxidants, one or more auxiliary blowing agents, one or more urethane catalysts, one or more auxiliary trimerisation catalysts, or combinations thereof; (5) contacting said one or more monomers, and said polyol, and optionally said one or more surfactants, and optionally said one or more flame retardants, and optionally said water, and optionally said one or more antioxidants, and optionally said one or more auxiliary blowing agents in the presence of said trimerisation catalyst system and optionally said one or more urethane catalysts, and optionally said one or more auxiliary trimerisation catalysts; (6) thereby forming said polyisocyanurate / polyurethane rigid foam. The PIR foam comprises the reaction product of one or more monomers selected from the group consisting of an isocyanate, a diisocyanate, a triisocyanatetriisocyanate, oligomeric isocyanate, a salt of any thereof, and a mixture any thereof with polyol in the presence of a trimerisation catalyst system comprising an imidazolium or imidazolinium cation, and an isocyanate-trimer inducing anion, and optionally one or more surfactants, optionally one or more flame retardants, optionally water, optionally one or more antioxidants, optionally one or more auxiliary blowing agents, optionally one or more additional urethane catalysts, and optionally one or more auxiliary trimerisation catalysts, or optionally combinations thereof, wherein the trimerisation catalyst system has a trimerisation activation temperature in the range of equal to or less than 73° C. The PIR foam comprises the reaction product of one or more monomers selected from the group consisting of an isocyanate, a diisocyanate, a triisocyanatetriisocyanate, oligomeric isocyanate, a salt of any thereof, and a mixture any thereof with polyol in the presence of a trimerisation catalyst system comprising an imidazolium or imidazolinium cation, and an isocyanate-trimer inducing anion, and optionally one or more surfactants, optionally one or more flame retardants, optionally water, optionally one or more antioxidants, optionally one or more auxiliary blowing agents, optionally one or more additional polyurethane catalysts, and optionally one or more auxiliary trimerisation catalysts, or optionally combinations thereof, wherein the PIR foam has a polyisocyanurate trimer ratio (Abs1410 / Abs1595) of at least 5 at a depth of 12 mm from the rising surface of the rigid foam, measured via ATR-FTIR spectroscopy.

This invention provides a first composition comprising a pharmaceutically acceptable particle and a stable HIV-1 pre-fusion envelope glycoprotein trimeric complex operably affixed thereto. This invention further provides a second composition comprising (a) a pharmaceutically acceptable particle, (b) an antigen, and (c) an agent which is operably affixed to the particle and is specifically bound to the antigen, whereby the antigen is operably bound to the particle. Finally, this invention provides related nucleic acids, vectors, cells, compositions, production methods, and prophylactic and therapeutic methods.

A low-free radical TDI polyurethane curing agent, its production and product are disclosed. The process is carried out by putting tolylene-diisoester cyanate, solvent S and catalyst A into reactor, adding into antioxidant and long-chain alcohol, agitating in reactor, heating, keeping temperature, inspecting NCO value, adding into phase-transferring solvent X while reaching NCO value to 20-40%, adding into catalyst B till reaching NCO value to 10-15, adding into inhibitor to stop reaction, adding into solvent S, decreasing pressure, distilling and removing phase-transferring solvent X. It's cheap and convenient.

The invention relates to a novel process for preparing low-monomer-content trimers based on 2,4- and 2,6-diisocyanatotoluene (TDI) and to the use thereof in coatings. The trimers are produced from a mixture of from 20 to 80% by weight of diisocyanate component containing at least 80% by weight of 2,4- and / or 2,6-diisocyanatotoluene and from 20 to 80% by weight of solvents and / or diluents and also phenolic catalysts containing dialkylaminomethyl groups.

The present invention relates to a polyurethane curing agent with low free isocyanate monomer and a preparation method thereof. The polyurethane curing agent comprises the raw materials in weight percentage as following: 80 - 88 parts of hexamethylene diisocyanate monomer; 12 - 20 parts of polyhydric alcohol; 0.1-0.5 part of catalyst; and 0.1-1.0 part of terminating agent. The invention adopts a two-step chemical conversion reaction, namely, adds one step of polymerization reaction based on one-step addition reaction to remove free isocyanate monomer by a trimer method so as to obtain the 100% solid content, wherein the NCO content is between 21 and 22 %, and the free HDI content is between 0.1 and 1.0 %. According to the present invention, the preparation process of polyurethane curing agent is simplified without post-processing . The polyurethane curing agent of the invention is matched with hydroxyl acrylic resin and polyester resin etc., and the paint film will not be yellowed, and has excellent light resistance, weathering resistance, chemical resistance and gorgeous gloss.

The present invention relates to the design of trimeric polypeptides using polypeptide structural elements derived from the tetranectin protein family, and their use in rational de novo design and production of multi-functional molecules including the application of the multi-functional molecules in protein library technology, such as phage display technology, diagnostic and therapeutic systems, such as human gene therapy and imaging. The trimeric polypeptides being constructed as a monomer polypeptide construct comprising at least one tetranectin trimerising structural element (TTSE) which is covalently linked to at least one heterologous moiety, said TTSE being capable of forming a stable complex with two other TTSEs; or as an oligomer which is comprised of two monomer polypeptide constructs as mentioned above, and which comprises three TTSEs or a multiplum of three TTSEs, or which is comprised of three monomer polypeptide constructs.

The invention discloses macrocyclic and cage-like molecules based on biphenylarene and derivatives of the macrocyclic and cage-like molecules as well as synthetic methods and applications of the macrocyclic and cage-like molecules and the derivatives. A series of novel macrocycles are obtained mainly by performing a reaction on bis(2,4-dialkoxyphenyl)arenes (naphthalene, anthracene, pyrene, porphyrin and the like) or tris(2,4-dialkoxyphenyl)arenes (benzene, sym-tribenzobenzene) and paraformaldehyde under the catalysis of a Lewis acid in high yield. In addition, perhydroxybiphenylarenes (quaterphenyl trimer, naphthalene dimer and the like) can be obtained by performing demethylation, a plurality of water-soluble derivatives can be obtained by performing further modification, and the derivatives show good bonding ability to guest molecules (viologen and the like); and moreover, functional groups introduced into the framework make the biphenylarene have excellent adsorption and separationability and photophysical properties. The compounds, derivatives and methods provided by the invention have the following advantages: raw materials of the biphenylarene are commercially available, the synthesis is simple and convenient, the yield is high, and the modification is convenient, so that the compounds and the derivatives have broad application prospects in gas adsorption and separation, performance improvement of light-emitting materials, and adsorption of water-soluble toxic substances.

The invention discloses a phosphazene flame retardant and a preparation method thereof. The phosphazene flame retardant is obtained through the reaction of fluorocarbon alcohol and phosphonitrilic chloride trimer, wherein, as the phosphazene flame retardant contains the elements of P and N, the flame-retardant effect is more obvious; as at least one of Rf1, Rf2, Rf3, Rf4, Rf5 and Rf6 is a fluorocarbon group which provides convenience for enhancing the flashing points of the electrolyte and reducing the viscosity of the electrolyte, the viscosity of the phosphazene flame retardant is proper, and the phosphazene flame retardant has favorable systematic consistence; moreover, the O bond and the P bond on the side chain of the phosphazene flame retardant are connected to a P group of a loop chain at the same time, so as to form a V-shaped hole, which provides convenience for absorbing metal positive ions to get far away from corresponding negative ions as well as for the migration of the positive ions, and further improves the electric conductivity of the electrolyte. The invention further provides a lithium ion battery electrolyte comprising electrolyte salt, a solvent and the phosphazene flame retardant. Experimental results show that the lithium ion battery electrolyte provided by the invention has favorable conductibility.

The invention discloses a water-dispersible HDI-TDI mixed tripolymer curing agent and a preparation method thereof. The method comprises steps as follows: (1) diisocyanate monomers and a nonionic hydrophilic modifying agent are put into a round-bottom flask under the protection of nitrogen and heated to reach 50-70 DEG C for a thermal reaction; (2) after the mixture reacts for 2-4 h, a trimerization catalyst is added, the mixture is subjected to a thermal reaction continuously, a polymerization inhibitor is added after the percentage composition of -NCO of the system reaches the target, and the mixture is subjected to the thermal reaction for 0.5-1.5 h; (3) an anion hydrophilic modifying agent is added to a tripolymer obtained in the step (2), the mixture is continuously stirred and subjected to the thermal reaction at the temperature of 60-80 DEG C, a neutralizing agent is added after the mixture reacts for 5-7 h, and the mixture is stirred uniformly, subjected to the thermal reaction for 0.5-1.5 h and discharged after being cooled. The preparation method is simple, and the prepared curing agent has the advantages of good water dispersibility, good storage stability and good film water resistance and can be applied to a water-based bi-component polyurethane coating well.

The present invention refers to fusion proteins comprising a TNF superfamily (TNFSF) cytokine or a receptor binding domain thereof fused to a trimerization domain and a nucleic acid molecule encoding the fusion protein. The fusion protein is present as a trimeric complex or as an oligomer thereof and is suitable for therapeutic, diagnostic and / or research applications.

The invention belongs to the technical field of curing agents and discloses a high-solid and averaged-molecular weight non-toxic polyurethane curing agent for a sub-gloss varnish and a preparation method thereof. The method comprises the steps of (1) in the nitrogen protection environment, adding a catalyst drop by drop in a reaction vessel filled with a solvent and toluene diisocynate during the stirring process, reacting at the temperature of 40-55 DEG C, cooling on the condition that the content of NCO is lowered to be 13%-23%, and adding an acidic polymerization inhibitor to obtain a toluene diisocyanate trimer; (2) mixing a polyhydroxy compound with a dehydrating agent, adding the obtained mixture in the toluene diisocyanate drop by drop, reacting and cooling to obtain a polyurethane addition product; (3) stirring and mixing the toluene diisocyanate trimer with the polyurethane addition product, separating in a film evaporator, adding a dilution solvent and stirring evenly to obtain the high-solid and averaged-molecular weight non-toxic polyurethane curing agent. The curing agent is centralized in the distribution of molecular weight, low in viscosity, and high in content of effective isocyanate groups. After a varnish is prepared by the curing agent, a paint film is fast in drying speed, good in levelability and high in fullness.

This self-repairing polyurethane resin raw material is obtained by reacting a polyisocyanate compound having an aliphatic polyisocyanate and / or an araliphatic polyisocyanate and an active hydrogen containing compound, is used in the production of a polyurethane resin having self-repairing properties, and has an isocyanate group at the molecular terminal. The self-repairing polyurethane resin raw material contains an allophanate group and an isocyanate trimer, and has a 0.1-20 molar ratio of allophanate groups to isocyanate trimers.

This invention provides a protein comprising (a) a first polypeptide which comprises consecutive amino acids, the sequence of which corresponds to the sequence of a modified gp120 envelope polypeptide portion of a gp140 envelope of (i) an HIV-I KNH1144 isolate, or a quasi-species thereof, or (ii) an HIV-I 5768.4 isolate, or a quasi-species thereof; and (b) a second polypeptide which comprises consecutive amino acids, the sequence of which corresponds to the sequence of a modified gp41 ectodomain polypeptide portion of the gp140 envelope of (i) the HIV-I KNH1144 isolate or such quasi-species thereof, or (ii) the HIV-I 5768.4 isolate or such quasi-species thereof. This invention also provides nucleic acids encoding such proteins, vectors, host cells and compositions thereof. Also provided are trimeric complexes (‘trimers’) of these proteins and methods of using such trimers to combat HIV-I infection.

The invention belongs to the field of flame-retardant auxiliaries of epoxy resin, and discloses a flame-retardant curing agent containing a phosphazene / aromatic imine composite structure and a preparation method thereof. The flame-retardant curing agent is composed of cyclotriphosphazene, aromatic imine and active amino groups, and the structural formula of the flame-retardant curing agent is shown in a formula I which is described in the specification. According to the invention, phosphonitrilic chloride trimer is subjected to substitution and condensation reactions with hydroxyl-containing aldehydes and aromatic diamines in sequence respectively so as to successfully prepare the phosphonitrile / aromatic imine composite structure-containing flame-retardant curing agent containing the polyfunctional active amino groups at the tail end. The whole preparation process has the characteristics of mild reaction conditions, controllable and adjustable reaction process, higher yield and the like, so the method is suitable for expanded production. According to the flame-retardant curing agent prepared by the invention, the contained active amino groups undergoes chemical reactions such as curing cross-linking with matrix epoxy resin and directly participates in forming of a polymer network three-dimensional structure to introduce a flame-retardant structure, so the prepared polymer material has excellent flame-retardant performance.

The present invention refers to a fusion protein comprising a TNF-superfamily (TNFSF) cytokine or a receptor binding domain thereof fused to a collectin trimerization domain, to a nucleic acid molecule encoding the fusion protein, and to a cell comprising the nucleic acid molecule. The fusion protein is present as a trimeric complex or as an oligomer thereof. The fusion protein, the nucleic acid, and the cell is suitable as pharmaceutical composition or for therapeutic, diagnostic and / or research applications.